RxDoctor Payments Data

Marcus Earle, DO

Family Medicine · New Bern, NCNPI 1417290255

Payments from drug & device makers

$2,794in general payments, 2019–2025

Across 163 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$322
  • GSK$206
  • Grifols USA, LLC$188
  • Novo Nordisk$186
  • Amgen$178
  • AstraZeneca$165
  • plus $2K from 45 others

What the payments were for

  • Food & beverage$2,794100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,794 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$667,535
Medicare patients
615
Services billed
40,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide70$74,489
JardianceEmpagliflozin63$64,663
EliquisApixaban70$50,763
OzempicSemaglutide35$49,538
XareltoRivaroxaban28$25,399
MyrbetriqMirabegron16$12,998
MounjaroTirzepatide11$11,516
InvokanaCanagliflozin14$11,298
FarxigaDapagliflozin Propanediol14$7,758
LinzessLinaclotide11$5,853
Atorvastatin Calcium556$4,774
Tresiba Flextouch U-100Insulin Degludec15$4,687
Fluticasone-SalmeterolFluticasone Propion/Salmeterol29$3,986
ShingrixVaricella-Zoster Ge/As01b/Pf16$3,564
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$3,185

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$68$86,00581 claims
Boehringer IngelheimJardiance$51$64,66363 claims
PfizerEliquis, Premarin$69$52,06282 claims
Novo NordiskOzempic$186$49,53835 claims
Johnson & JohnsonXarelto, Invokana$141$36,69842 claims
Astellas Pharma US IncMyrbetriq$16$12,99816 claims
AstraZenecaFarxiga, Symbicort$165$10,35625 claims
AbbVieLinzess, Synthroid$322$7,81139 claims
GSKShingrix$206$3,56416 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$24$1,880219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in New Bern

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →